Indeed, it has been recently suggested that supplementation with DHA can be an effective treatment against spinocerebellar ataxia 38 (SCA38) a syndrome characterized by the mutation in the ELOVL5 gene that encodes an elongase enzyme responsible for very low chain fatty acids in the cerebellum [133]. This evidence concerns the gene ELOVL5 and Spinocerebellar ataxia type 38.